The Asia Pacific Advocates for Tobacco Harm Reduction Alliance (CAPHRA) has launched a new series of e-cigarettes that expose the anti-vaping campaign in Australia. According to Nancy Loucas, CAPHRA Executive Coordinator, "fortunately, the unpleasant truth about e-cigarettes is now available on laptops of Australians, debunking all the scaremongering propaganda being sold by health agencies and officials against vaping.
Prior to Ms. Loucas' commentary, Dr. Colin Mendelsohn, an Australian tobacco harm reduction expert, released a series of eight evidence-based, short videos about e-cigarettes to debunk misinformation provided by Dr. Karl Kruszelnicki to the Queensland Health Department.
Queensland, New South Wales, and Western Australia are investing a significant amount of public funds into an inaccurate anti-vaping campaign. As a result, adult smokers in Australia are being actively discouraged from switching to less harmful nicotine alternatives. Dr. Col's "Vape Truths" thoroughly exposes Australia's unfounded anti-vaping stance and is well worth a read, according to her.
Dr. Mendelsohn's eight-part video series reveals that the toxicity of vapor is significantly lower than that of cigarette smoke. Compared to smoking, e-cigarettes significantly reduce the risk of cancer and have never been linked to deaths caused by nicotine ingestion. When smokers switch to e-cigarettes, their breathing greatly improves. The doses of most chemicals in vapor are very low, and many are harmless or carry minimal risks.
The overall smoking rate in Australia has remained almost unchanged in recent years, while in New Zealand it has decreased by half over the past decade. New Zealand is promoting e-cigarettes as an effective smoking cessation tool, while Australia's "quit or die" tobacco control approach has failed its 2.3 million smokers severely, according to Ms. Loucas.
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) has stated that Australia is falling behind the Asia Pacific region when it comes to regulating electronic cigarettes. They mentioned that the Philippines is the latest country to regulate the import, manufacture, sale, packaging, distribution, and use of e-cigarettes.
The "Vaporized Nicotine and Non-Nicotine Products Regulation Act" became a law on July 25 in the Philippines, and local health experts believe it will help reduce the incidence of serious illnesses and deaths caused by smoking.
CAPHRA has stated that Australia is the only Western democratic country where a nicotine prescription is required to consume electronic cigarettes, which is absurd.
Approximately 70 countries worldwide regulate safer nicotine products, but health leaders in Australia continue to prohibit adult retail. Medicalization makes it more difficult for smokers to switch to e-cigarettes and makes Australia's goal of reducing smoking rates by 10% nearly impossible. In contrast, New Zealand aims for smoke-free with only 5% or fewer New Zealanders smoking,” she said.
CAPHRA believes that Dr. Mendelsohn's latest counterattack movement confirms that the ongoing panic and hysteria surrounding e-cigarettes in Australia is completely unfounded.
These inconvenient facts also expose the World Health Organization's (WHO) continued refusal to acknowledge that an increasing amount of international scientific evidence confirms that the harm from e-cigarettes is far less than from smoking," she said.
Approximately 20,000 Australian smokers die prematurely each year due to smoking-related illnesses. CAPHRA believes that if Australia is serious about reducing this alarming annual death toll, politicians and health officials should rely less on the World Health Organization and instead listen more to Dr. Mendelsohn, the scientific community, and the international society.
The inevitable failure of the e-cigarette ban has been seen as the Philippines recently lifted its ban, with Malaysia and Thailand set to follow suit. Dr. Col's Vape Truths video series has timely exposed Australia's increasingly isolated and untenable position on e-cigarettes. "This is a must-watch for any skeptics," says Nancy Loucas.
This article is compiled from third-party information sources and is intended for industry-related communication and learning purposes.
This article does not reflect the views of 2FIRSTS and 2FIRSTS is unable to confirm the authenticity and accuracy of its content. The compilation of this article is only intended for industry communication and research.
Due to the limitations in the level of translation, the compiled article may not fully express the same meaning as the original. Therefore, it is recommended to refer to the original article for accuracy.
In all domestic, Hong Kong, Macau, Taiwan, and foreign affairs, 2FIRSTS maintains complete alignment with the Chinese government's positions and statements.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
